Allergy Associates of the Palm Beaches

Recent papers from Allergy Associates of the Palm Beaches

1. Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiencyImmunotherapy · 2026
2. Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study)Advances in Therapy · 2026
3. Large-scale deep learning analysis to identify adult patients at risk for combined and common variable immunodeficienciesCommunications Medicine · 2023
4. Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion RegimensJournal of Clinical Immunology · 2023
5. Towards an FDA-cleared basophil activation testFrontiers in Allergy · 2023
6. Future of Therapy for Inborn Errors of ImmunityClinical Reviews in Allergy & Immunology · 2022
7. Women with disabilities in hearing: the last mile in the elimination of mother-to-child transmission of HIV – a cross-sectional study from ZambiaAIDS Care · 2021
8. Facing the quality of life: physical illness, anxiety, and depression symptoms among people living with HIV in rural Zambia – a cross-sectional studyAIDS Care · 2021
9. Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary ImmunodeficienciesFrontiers in Immunology · 2021
10. Isolated Swelling of the Uvula in a 2-year-old GirlPediatrics in Review · 2021
11. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and ManagementTyöväentutkimus Vuosikirja · 2020
12. Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continentsImmunotherapy · 2019
13. Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseasesAnnals of Allergy Asthma & Immunology · 2019
14. Dermatology EmergenciesJournal of the Dermatology Nurses’ Association · 2018
15. Specific Antibody Deficiency: Controversies in Diagnosis and ManagementFrontiers in Immunology · 2017
16. Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North AmericaJournal of Clinical Immunology · 2016
17. Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency DiseaseJournal of Clinical Immunology · 2016
18. Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary ImmunodeficiencyJournal of Clinical Immunology · 2016
19. Dermatology EmergenciesJournal of the Dermatology Nurses’ Association · 2016
20. Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapyAllergy Asthma and Clinical Immunology · 2014